In our study, TRF (60 and 120 mg/kg) treatments in T2DM VaD rats were able to ameliorate the oxidative stress by increasing the GSH and SOD levels; this effect further shows its potential as an antioxidant in the brain to act as neuroprotective. Here, SOD1 is linked to type 2 diabetes mellitus.